Angina pectoris in women: Focus on microvascular disease

International Journal of Cardiology

Volumn 163, Issue 2, 2013, Pages 132-140

  Zuchi, Cinzia ^a   Tritto, Isabella ^a   Ambrosio, Giuseppe ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Angina pectoris; Antianginal drugs; Ischemic heart disease; Microcirculation; Women

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMINOPHYLLINE; AMLODIPINE; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CILAZAPRIL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; ESTRADIOL; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; IVABRADINE; LIDOFLAZINE; METFORMIN; METOPROLOL; NIFEDIPINE; NITRATE; PLACEBO; PRAVASTATIN; PROPRANOLOL; RAMIPRIL; RANOLAZINE; SIMVASTATIN; UNINDEXED DRUG; VERAPAMIL; ANTIANGINA PECTORIS AGENT; ARGININE; ISOSORBIDE MONONITRATE; NITRIC ACID DERIVATIVE;

ANGINA PECTORIS; CARDIOVASCULAR RISK; COMORBIDITY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MICROCIRCULATION; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PATHOGENESIS; PREDICTIVE VALUE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STABLE ANGINA PECTORIS; SURVIVAL RATE; SYMPTOMATOLOGY; SYNDROME X; THORAX PAIN; TREATMENT DURATION; TREATMENT RESPONSE; ANGIOCARDIOGRAPHY; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; EVIDENCE BASED MEDICINE; FEMALE; HIGH RISK POPULATION; META ANALYSIS (TOPIC); MICROANGIOPATHY; MORBIDITY; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION;

ANGINA PECTORIS; FEMALE; HUMANS; MALE; MICROVASCULAR ANGINA; MYOCARDIAL ISCHEMIA; PROGNOSIS; SEX FACTORS;

EID: 84873409611     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.07.001     Document Type: Review

References (115)

1. W. Rosamond, K. Flegal, and G. Friday Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 115 2007 e69 e171
2. S.P.V. Peterson, M. Rayner, R. Luengo-Fernandez, and A. Gray European cardiovascular disease statistics 2nd ed. 2005 British Heart Foundation London
3. H. Hemingway, C. Langenberg, J. Damant, C. Frost, K. Pyorala, and E. Barrett-Connor Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries Circulation 117 2008 1526 1536
4. C.N. Bairey Merz, L.J. Shaw, and S.E. Reis Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease J Am Coll Cardiol 47 2006 S21 S29
5. L.J. Shaw, C.N. Bairey Merz, and C.J. Pepine Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies J Am Coll Cardiol 47 2006 S4 S20
6. B.L. Sharaf, C.J. Pepine, and R.A. Kerensky Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory) Am J Cardiol 87 2001 937 941 [A3]
7. W. Likoff, B.L. Segal, and H. Kasparian Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease N Engl J Med 276 1967 1063 1066
8. L.J. Shaw, R.E. Shaw, and C.N. Merz Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry Circulation 117 2008 1787 1801
9. L.J. Shaw, C.N. Merz, and C.J. Pepine The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation Circulation 114 2006 894 904
10. P. Ong, A. Athanasiadis, G. Borgulya, H. Mahrholdt, J.C. Kaski, and U. Sechtem High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries) J Am Coll Cardiol 59 2012 655 662
11. L. Jespersen, A. Hvelplund, and S.Z. Abildstrom Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events Eur Heart J 33 6 2012 Mar 734 744
12. C. Daly, F. Clemens, and J.L. Lopez Sendon Gender differences in the management and clinical outcome of stable angina Circulation 113 2006 490 498
13. R.C. Pasternak, J. Abrams, P. Greenland, L.A. Smaha, P.W. Wilson, and N. Houston-Miller 34th Bethesda Conference: task force #1 - identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol 41 2003 1863 1874
14. P.M. Ridker, J.E. Buring, N. Rifai, and N.R. Cook Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 2007 611 619
15. F. Angeli, E. Angeli, G. Ambrosio, G. Mazzotta, G. Reboldi, and P. Verdecchia Neutrophil count for the identification of postmenopausal hypertensive women at increased cardiovascular risk Obstet Gynecol 115 2010 695 703
16. NHS-National Institute for Health and Clinical Excellence Management of stable angina 2011 National Clinical Guideline Centre www.nice.org.uk/guidance/ CG126
17. M.J. Zaman, C. Junghans, and N. Sekhri Presentation of stable angina pectoris among women and South Asian people CMAJ 179 2008 659 667
18. C.J. Pepine, J. Abrams, R.G. Marks, J.J. Morris, S.S. Scheidt, and E. Handberg Characteristics of a contemporary population with angina pectoris. TIDES Investigators Am J Cardiol 74 1994 226 231
19. L.P. Kimble, D.B. McGuire, and S.B. Dunbar Gender differences in pain characteristics of chronic stable angina and perceived physical limitation in patients with coronary artery disease Pain 101 2003 45 53
20. D.S. Sheps, P.G. Kaufmann, and D. Sheffield Sex differences in chest pain in patients with documented coronary artery disease and exercise-induced ischemia: results from the PIMI study Am Heart J 142 2001 864 871
21. M. Mohri, M. Koyanagi, and K. Egashira Angina pectoris caused by coronary microvascular spasm Lancet 351 1998 1165 1169
22. S. Jadhav, W. Ferrell, I.A. Greer, J.R. Petrie, S.M. Cobbe, and N. Sattar Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study J Am Coll Cardiol 48 2006 956 963
23. J.C. Kaski, G.M. Rosano, P. Collins, P. Nihoyannopoulos, A. Maseri, and P.A. Poole-Wilson Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study J Am Coll Cardiol 25 1995 807 814
24. I.A. Vermeltfoort, P.G. Raijmakers, and I.I. Riphagen Definitions and incidence of cardiac syndrome X: review and analysis of clinical data Clin Res Cardiol 99 2010 475 481
25. A. Chauhan, P.A. Mullins, G. Taylor, M.C. Petch, and P.M. Schofield Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms Eur Heart J 18 1997 60 68
26. F. Rigo, L. Pratali, and A. Palinkas Coronary flow reserve and brachial artery reactivity in patients with chest pain and false positive exercise-induced ST-segment depression Am J Cardiol 89 2002 1141 1144
27. P.G. Camici, P. Marraccini, and R. Lorenzoni Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress J Am Coll Cardiol 17 1991 1461 1470
28. NHS-National Institute for Health and Clinical Excellence Chest pain of recent onset 2010 National Clinical Guideline Centre www.nice.org.uk/guidance/ CG95
29. Y. Kwok, C. Kim, D. Grady, M. Segal, and R. Redberg Meta-analysis of exercise testing to detect coronary artery disease in women Am J Cardiol 83 1999 660 666
30. A.P. Morise, J.N. Dalal, and R.D. Duval Value of a simple measure of estrogen status for improving the diagnosis of coronary artery disease in women Am J Med 94 1993 491 496
31. M.A. Hlatky, D.B. Pryor, F.E. Harrell Jr., R.M. Califf, D.B. Mark, and R.A. Rosati Factors affecting sensitivity and specificity of exercise electrocardiography multivariable analysis Am J Med 77 1984 64 71
32. P. Guiteras, B.R. Chaitman, and D.D. Waters Diagnostic accuracy of exercise ECG lead systems in clinical subsets of women Circulation 65 1982 1465 1474
33. S.M. Barolsky, C.A. Gilbert, A. Faruqui, D.O. Nutter, and R.C. Schlant Differences in electrocardiographic response to exercise of women and men: a non-Bayesian factor Circulation 60 1979 1021 1027
34. J.H. Mieres, L.J. Shaw, and A. Arai Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association Circulation 111 2005 682 696
35. E. Handberg, B.D. Johnson, and C.B. Arant Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study J Am Coll Cardiol 47 2006 S44 S49
36. C.J. Pepine, R.A. Kerensky, and C.R. Lambert Some thoughts on the vasculopathy of women with ischemic heart disease J Am Coll Cardiol 47 2006 S30 S35
37. S.E. Sheifer, M.R. Canos, and K.P. Weinfurt Sex differences in coronary artery size assessed by intravascular ultrasound Am Heart J 139 2000 649 653
38. B. De Bruyne, F. Hersbach, and N.H. Pijls Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "normal" coronary angiography Circulation 104 2001 2401 2406
39. L. Nugent, P.K. Mehta, and C.N. Bairey Merz Gender and microvascular angina J Thromb Thrombolysis 31 2011 37 46
40. G.A. Lanza, and F. Crea Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management Circulation 121 2010 2317 2325
41. V. Vaccarino, L. Badimon, and R. Corti Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position Paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology Cardiovasc Res 90 1 2011 Apr 1 9 17
42. A.M. Zeiher, T. Krause, V. Schachinger, J. Minners, and E. Moser Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia Circulation 91 1995 2345 2352
43. K. Egashira, T. Inou, Y. Hirooka, A. Yamada, Y. Urabe, and A. Takeshita Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms N Engl J Med 328 1993 1659 1664
44. D. Opherk, G. Mall, and H. Zebe Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries Circulation 69 1984 1 7
45. S.E. Reis, R. Holubkov, and A.J. Conrad Smith Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study Am Heart J 141 2001 735 741
46. S.E. Reis, R. Holubkov, and J.S. Lee Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study J Am Coll Cardiol 33 1999 1469 1475
47. S.D. Buchthal, J.A. den Hollander, and C.N. Merz Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms N Engl J Med 342 2000 829 835
48. B.D. Johnson, L.J. Shaw, and S.D. Buchthal Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Circulation 109 2004 2993 2999
49. A.R. Pries, H. Habazettl, and G. Ambrosio A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings Cardiovasc Res 80 2008 165 174
50. P.R. Lichtlen, K. Bargheer, and P. Wenzlaff Long-term prognosis of patients with anginalike chest pain and normal coronary angiographic findings J Am Coll Cardiol 25 1995 1013 1018
51. M. Radice, V. Giudici, and G. Marinelli Long-term follow-up in patients with positive exercise test and angiographically normal coronary arteries (syndrome X) Am J Cardiol 75 1995 620 621
52. B.D. Johnson, L.J. Shaw, and C.J. Pepine Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study Eur Heart J 27 2006 1408 1415
53. G.O. von Mering, C.B. Arant, and T.R. Wessel Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Circulation 109 2004 722 725
54. C.J. Pepine, R.D. Anderson, and B.L. Sharaf Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study J Am Coll Cardiol 55 2010 2825 2832
55. J.P. Halcox, W.H. Schenke, and G. Zalos Prognostic value of coronary vascular endothelial dysfunction Circulation 106 2002 653 658
56. J.A. Suwaidi, S. Hamasaki, S.T. Higano, R.A. Nishimura, D.R. Holmes Jr., and A. Lerman Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction Circulation 101 2000 948 954
57. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
58. R. Holubkov, W.K. Laskey, and A. Haviland Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry Am Heart J 144 2002 826 833
59. J.P. Curtis, G. Schreiner, and Y. Wang All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients J Am Coll Cardiol 54 2009 903 907
60. P.W. Serruys, M.C. Morice, and A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
61. I. Tritto, G.A. Lanza, and F. Rigo Long-term prognosis of patients with cardiac syndrome X: data from the Italian Registry of Syndrome X (RISX) J Am Coll Cardiol 35 2009 A343
62. G. Cocco, and D. Chu The anti-ischemic effect of metoprolol in patients with chronic angina pectoris is gender-specific Cardiology 106 2006 147 153
63. M.B. Olson, S.F. Kelsey, and K. Matthews Symptoms, myocardial ischaemia and quality of life in women: results from the NHLBI-sponsored WISE Study Eur Heart J 24 2003 1506 1514
64. H. Hemingway, A. McCallum, M. Shipley, K. Manderbacka, P. Martikainen, and I. Keskimaki Incidence and prognostic implications of stable angina pectoris among women and men JAMA 295 2006 1404 1411
65. N. Jochmann, K. Stangl, E. Garbe, G. Baumann, and V. Stangl Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases Eur Heart J 26 2005 1585 1595
66. A.B. Luzier, A. Killian, J.H. Wilton, M.F. Wilson, A. Forrest, and D.J. Kazierad Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers Clin Pharmacol Ther 66 1999 594 601
67. M. Stramba-Badiale Women and research on cardiovascular diseases in Europe: a report from the European Heart Health Strategy (EuroHeart) project Eur Heart J 31 2010 1677d 1681d
68. P.A. Heidenreich, K.M. McDonald, and T. Hastie Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina JAMA 281 1999 1927 1936
69. R. Bugiardini, A. Borghi, L. Biagetti, and P. Puddu Comparison of verapamil versus propranolol therapy in syndrome X Am J Cardiol 63 1989 286 290
70. G.A. Lanza, G. Colonna, V. Pasceri, and A. Maseri Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X Am J Cardiol 84 1999 854 856 [A8]
71. G. Fragasso, S.L. Chierchia, and G. Pizzetti Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effect of beta adrenergic blockade Heart 77 1997 32 39
72. G. Sutsch, E. Oechslin, I. Mayer, and O.M. Hess Effect of diltiazem on coronary flow reserve in patients with microvascular angina Int J Cardiol 52 1995 135 143
73. A. Masumoto, M. Mohri, and A. Takeshita Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm Int J Cardiol 81 2001 151 156
74. H. Yoshio, M. Shimizu, and Y. Kita Effects of short-term aminophylline administration on cardiac functional reserve in patients with syndrome X J Am Coll Cardiol 25 1995 1547 1551
75. P.M. Elliott, K. Krzyzowska-Dickinson, R. Calvino, C. Hann, and J.C. Kaski Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X) Heart 77 1997 523 526
76. C. Pizzi, O. Manfrini, F. Fontana, and R. Bugiardini Angiotensin- converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X: role of superoxide dismutase activity Circulation 109 2004 53 58
77. J.C. Kaski, G. Rosano, S. Gavrielides, and L. Chen Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina J Am Coll Cardiol 23 1994 652 657
78. J.W. Chen, N.W. Hsu, T.C. Wu, S.J. Lin, and M.S. Chang Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X Am J Cardiol 90 2002 974 982
79. I. Nalbantgil, R. Onder, and A. Altintig Therapeutic benefits of cilazapril in patients with syndrome X Cardiology 89 1998 130 133
80. E. Fabian, A. Varga, E. Picano, Z. Vajo, A. Ronaszeki, and M. Csanady Effect of simvastatin on endothelial function in cardiac syndrome X patients Am J Cardiol 94 2004 652 655
81. M. Kayikcioglu, S. Payzin, O. Yavuzgil, H. Kultursay, L.H. Can, and I. Soydan Benefits of statin treatment in cardiac syndrome-X1 Eur Heart J 24 2003 1999 2005
82. D.T. Nash, and S.D. Nash Ranolazine for chronic stable angina Lancet 372 2008 1335 1341
83. L. Belardinelli, J.C. Shryock, and H. Fraser Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine Heart 92 Suppl. 4 2006 iv6 iv14
84. Y.K. Ju, D.A. Saint, and P.W. Gage Hypoxia increases persistent sodium current in rat ventricular myocytes J Physiol 497 Pt. 2 1996 337 347
85. A.I. Undrovinas, I.A. Fleidervish, and J.C. Makielski Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine Circ Res 71 1992 1231 1241
86. E. Murphy, M. Perlman, R.E. London, and C. Steenbergen Amiloride delays the ischemia-induced rise in cytosolic free calcium Circ Res 68 1991 1250 1258
87. O.H. Bing, J.F. Keefe, M.J. Wolk, L.J. Finkelstein, and H.J. Levine Tension prolongation during recovery from myocardial hypoxia J Clin Invest 50 1971 660 666
88. W. Hayashida, C. van Eyll, M.F. Rousseau, and H. Pouleur Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease Cardiovasc Drugs Ther 8 1994 741 747
89. L. Belardinelli, J.C. Shryock, and H. Fraser The mechanism of ranolazine action to reduce ischemia-induced distolic dysfunction Eur Heart J 8 2006 A10 A13
90. P.K. Mehta, P. Goykhman, and L.E. Thomson Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease JACC Cardiovasc Imaging 4 2011 514 522
91. B.R. Chaitman, S.L. Skettino, and J.O. Parker Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina J Am Coll Cardiol 43 2004 1375 1382
92. B.R. Chaitman, C.J. Pepine, and J.O. Parker Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial JAMA 291 2004 309 316
93. P.H. Stone, N.A. Gratsiansky, A. Blokhin, I.Z. Huang, and L. Meng Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial J Am Coll Cardiol 48 2006 566 575
94. M.F. Rousseau, H. Pouleur, G. Cocco, and A.A. Wolff Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris Am J Cardiol 95 2005 311 316
95. N.K. Wenger, B. Chaitman, and G.W. Vetrovec Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials Am J Cardiol 99 2007 11 18
96. M.J. Koren, M.R. Crager, and M. Sweeney Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE) J Am Coll Cardiol 49 2007 1027 1034
97. D.A. Morrow, B.M. Scirica, and E. Karwatowska-Prokopczuk Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA 297 2007 1775 1783
98. J.L. Mega, J.S. Hochman, and B.M. Scirica Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes - thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) Circulation 121 2010 1809 1817
99. M. Manz, M. Reuter, G. Lauck, H. Omran, and W. Jung A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction Cardiology 100 2003 149 155
100. J.S. Borer, K. Fox, P. Jaillon, and G. Lerebours Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial Circulation 107 2003 817 823
101. J.C. Tardif, P. Ponikowski, and T. Kahan Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial Eur Heart J 30 2009 540 548
102. J.C. Tardif, I. Ford, M. Tendera, M.G. Bourassa, and K. Fox Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina Eur Heart J 26 2005 2529 2536
103. W. Ruzyllo, M. Tendera, I. Ford, and K.M. Fox Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial Drugs 67 2007 393 405
104. R. Koster, J. Kaehler, and T. Meinertz Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study Am Heart J 158 2009 e51 e57
105. K. Fox, I. Ford, P.G. Steg, M. Tendera, and R. Ferrari Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 807 816
106. K. Fox, I. Ford, P.G. Steg, M. Tendera, M. Robertson, and R. Ferrari Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial Eur Heart J 30 2009 2337 2345
107. R.O. Cannon III, R.M. Watson, D.R. Rosing, and S.E. Epstein Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve Am J Cardiol 56 1985 242 246
108. P. Montorsi, S. Cozzi, and A. Loaldi Acute coronary vasomotor effects of nifedipine and therapeutic correlates in syndrome X Am J Cardiol 66 1990 302 307
109. R.O. Cannon III, J.E. Brush Jr., W.H. Schenke, C.M. Tracy, and S.E. Epstein Beneficial and detrimental effects of lidoflazine in microvascular angina Am J Cardiol 66 1990 37 41
110. G.A. Lanza, A. Manzoli, E. Bia, F. Crea, and A. Maseri Acute effects of nitrates on exercise testing in patients with syndrome X. Clinical and pathophysiological implications Circulation 90 1994 2695 2700
111. M. Radice, V. Giudici, and E. Pusineri Different effects of acute administration of aminophylline and nitroglycerin on exercise capacity in patients with syndrome X Am J Cardiol 78 1996 88 92
112. S.J. Russell, E.M. Di Stefano, M.T. Naffati, O. Brown, and S. Saltissi The effects of the angiotensin II receptor (type I) antagonist irbesartan in patients with cardiac syndrome X Heart 93 2007 253 254
113. G.M. Rosano, N.S. Peters, and D. Lefroy 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X J Am Coll Cardiol 28 1996 1500 1505
114. A. Lerman, J.C. Burnett Jr., S.T. Higano, L.J. McKinley, and D.R. Holmes Jr. Long-term l-arginine supplementation improves small-vessel coronary endothelial function in humans Circulation 97 1998 2123 2128
115. H.E. Botker, H.S. Sonne, O. Schmitz, and T.T. Nielsen Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X Am J Cardiol 82 1998 1352 1356